Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4901–4950 of 35157
On February 9, 2025, Karen Grimes notified TEGNA Inc. (the “Company”) of her decision to retire from the Company’s Board of Directors (the “Board”) and not to stand for re-election at the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”).
On February 6, 2025, Kathleen Love notified comScore, Inc. (the "Company") of her resignation from the Board of Directors of the Company, effective February 7, 2025.
Additionally, on February 11, 2025, Dr. Wang notified the board of directors (the “Board”) of his resignation as a member of the Board, effective February 11, 2025.
the Board increased the size of the Board from eleven to twelve directors and appointed a new director, Jed Rhoads, to the Board.
Pursuant to the terms of the TD stockholder agreement and the resignation letters, Mr. Levitt and Mr. Masrani resigned from the board of directors of the Company as of the effective date.
Pursuant to the terms of the TD stockholder agreement and the resignation letters, Mr. Levitt and Mr. Masrani resigned from the board of directors of the Company as of the effective date.
On January 22, 2025, Kwong Sang Liu resigned from his position as an independent director of the Board of Directors of the Company (the “ Board ”) and as member of the Nominating and Corporate Governance Committee of the Board, Chairman of the Audit Committee of the Board and member of the Compensation Committee of the Board.
Effective January 22, 2025, the Board appointed Zhelun Zhou as an independent director of the Board and as member of the Nominating and Corporate Governance Committee of the Board, Chairman of the Audit Committee of the Board and member of the Compensation Committee of the Board, to fill the vacancy created by the resignation of Kwong Sang Liu.
On December 21, 2024, the Company reported the appointment of Mr. Lyndon (Lincoln) Hsu to the Company’s Board of Directors.
On February 7, 2025, Christopher J. Valasek resigned as a director of Boxabl Inc. (the “Company”).
On February 6, 2025, Jonathan W. Hinton, a member of the Board of Directors (the "Board") of Southern States Bancshares, Inc. (the "Company") notified the Board that he does not intend to stand for re-election to the Company’s Board following the expiration of his current term.
On February 10, 2025, the Company’s Board of Directors (the “Board”) appointed Alexander Kayyal to the Board as a Class I director, effective February 14, 2025.
On February 11, 2025 , the Board of Directors of Serina Therapeutics, Inc. (the “Company”) appointed Dr. Jay Venkatesan to the Company’s Board of Directors, effective February 12, 2025.
The Company also announced the departure of Dr. Milton Harris from its Board of Directors effective February 11, 2025 .
on February 7, 2025, Dr. John Paglia also notified the Board of his intention to resign as an independent director of the Company and as a member of each committee of the Board on which he served, effective as of March 7, 2025.
Mr. Donald R. Parfet announced his intention to retire from the Company’s Board of Directors and not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders on May 9, 2025.
appointed Shawn Sedaghat as a Class III director of the Company.
Timothy A. Holt, a member of the Board of Directors (the “Board”) of MGIC Investment Corporation (the “Corporation”) informed the Corporation that he does not intend to stand for re-election to the Board once his current term ends at the Annual Meeting of Shareholders to be held on April 24, 2025.
On February 10, 2025, (the “ Effective Date ”), the Board of Directors (the “ Board ”) of Cytokinetics, Incorporated (the “ Company ”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
each of David Boyce, Robert Galford and Yvonne Wassenaar decided to retire as a member of the Board of Directors effective as of the upcoming annual meeting and not stand for re-election.
each of David Boyce, Robert Galford and Yvonne Wassenaar decided to retire as a member of the Board of Directors effective as of the upcoming annual meeting and not stand for re-election.
each of David Boyce, Robert Galford and Yvonne Wassenaar decided to retire as a member of the Board of Directors effective as of the upcoming annual meeting and not stand for re-election.
appointed Leslie M. Turner as a member of the Board, effective February 19, 2025.
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
Simon Falk and Nina Fleck became the directors of the Company
Simon Falk and Nina Fleck became the directors of the Company
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
On February 7, 2025, Mary Curran informed the Company that she will retire from the Board and not stand for re-election when her term expires at the Company’s 2025 annual meeting of shareholders.
David Stecher informed Innovative Industrial Properties, Inc. (the “Company”) that he will retire from the Board and not stand for re-election when his term expires at the Company’s 2025 annual meeting of shareholders.
On February 7, 2025, Donald F. Textor informed the Board of Directors (Board) of EOG Resources, Inc. (EOG) of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at EOG’s 2025 annual meeting of stockholders (2025 Annual Meeting).
accepted the resignation of Carlyn R. Taylor from her position as a director of the Company effective immediately.
appointed David A. Robbie to serve as an independent director to the Board effective immediately.
On February 10, 2025, the Board appointed Michael Ketslakh to serve as a Class II Director of the Board, to fill the vacancy created by the resignation of Mr. Landers.
On February 5, 2025, Scott Landers announced his resignation from the Board of Directors (the “Board”) of Bridgeline Digital, Inc. (the “Company”), effective immediately.
On February 5, 2025, Herbert Conrad informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning from the Board effective February 6, 2025, due to retirement.
On February 6, 2025, Michael R. MacDonald, a member of the board of directors (the “Board”) of Frontier Group Holdings, Inc. (the “Company”) since 2016, notified the Board that he will retire from the Board effective on the date of the Company’s 2025 annual meeting of stockholders.
On February 5, 2025, James H. Forson, a member of the Board of Directors ("Board") of Invesco Real Estate Income Trust Inc. (the "Company") since 2019, informed the Company that he will retire from the Board and the Audit Committee, effective June 30, 2025.
On February 5, 2025, James H. Forson, a member of the Board of Directors ("Board") of Invesco Commercial Real Estate Finance Trust, Inc. (the "Company") since 2023, informed the Company that he will retire from the Board and the Audit Committee, effective June 30, 2025.
On January 29, 2025, Gary L. Dake notified the Board of Directors of Arrow Financial Corporation (the "Company") that he will retire from the Board after serving out the rest of his term which ends at the 2025 Annual Meeting.
On February 4, 2025, pursuant to the Company’s Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) and Amended and Restated Bylaws (“Bylaws”), the JBS Nominating Committee (the “JBS Nominating Committee”) of the Board of Directors (the “Board”) appointed Joanita Karoleski to the Board as a JBS Director.
In addition, Mr. Menon was re-appointed to the Board and re-classified by the JBS Nominating Committee from an Equity Director to a JBS Director.
On February 7, 2025, Robert T. Webb notified National Health Investors, Inc. (the “Company”) of his decision to resign from his position as a member of the Board of Directors (the “Board”) effective immediately.
Ms. Chaibi was also appointed to serve as a member of the Board as of the Effective Date, for a term expiring at the Company’s 2025 annual meeting of stockholders and until her successor is elected and qualified or until her earlier resignation or removal.
The Board also increased the size of the Board from eight to nine members and appointed Mr. Clark to serve as a Class II Board member.
On February 7, 2025, Maria Asuncion Aramburuzabala Larregui resigned as a director of the Board of Directors (the “Board”) of the Company after four years of service on the Board and the Remuneration and Nomination Committee.
On February 8, 2025, Sempra’s Board of Directors (the “Board”) appointed Anya Weaving, age 48, and Kevin C. Sagara, age 63, to serve on the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.